444722-03-6

Upstream product

• 90532-02-8 1-bromo-2-methyl-4-methylsulfanylbenzene 

Downstream Products

• 648905-32-2 1-(2-{4-[6-methoxy-2-(2-methyl-4-methylsulfanyl-phenyl)-naphthalen-1-yloxy]-phenoxy}-ethyl)-piperidine 
• 1032825-89-0 5-[2-methyl-4-(methylthio)phenyl]-2-pyrazinamine 
• 1032825-85-6 1,1-dimethylethyl 4-[({6-[2-methyl-4-(methylthio)phenyl]-3-pyridinyl}oxy)methyl]-1-piperidinecarboxylate 
• 1032825-88-9 5-[({1-[3-(1-methylethyl)-1,2,4-oxadiazol-5-yl]-4-piperidinyl}methyl)oxy]-2-[2-methyl-4-(methylthio)phenyl]pyridine 

Relevant academic research and scientific papers

BICYCLIC COMPOUNDS AND USE AS ANTIDIABETICS

The present invention relates to novel compounds that are useful in the treatment of metabolic disorders, particularly type II diabetes mellitus and related disorders, and also to the methods for the making and use of such compounds.

SELECTIVE ESTROGEN RECEPTOR MODULATORS CONTAINING A PHENYLSULFONYL GROUP

The present invention relates to a selective estrogen receptor modulator of formula I or a pharmaceutical acid addition salt thereof; useful, e.g., for treating endometriosis and/or uterine leiomyoma/leiomyomata.